Day One Biopharmaceuticals is a biotechnology company that focuses on developing precision medicines for patients with cancer. Their innovative approach combines cutting-edge science with a deep understanding of cancer biology to create targeted therapies. With a commitment to improving patient outcomes, Day One Biopharmaceuticals is poised to make a significant impact in the field of oncology.